What is Archimedic?
Archimedic operates as a specialized consultancy and development partner focused on the creation of safe, effective, and compliant medical devices. The company distinguishes itself through a rigorous adherence to international standards, maintaining a Quality Management System that is fully compliant with 21 CFR 820 FDA Quality System Regulation and ISO 13485:2016. By integrating deep technical expertise with stringent regulatory oversight, Archimedic serves as a critical bridge for organizations navigating the complex pathway from conceptual design to market-ready medical solutions. Their market position is defined by a commitment to excellence in engineering and a proactive approach to mitigating risk in the life sciences industry.
How much funding has Archimedic raised?
Archimedic has raised a total of $808K across 2 funding rounds:
Debt
$350K
Debt
$458K
Debt (2020): $350K with participation from PPP
Debt (2021): $458K led by PPP
Key Investors in Archimedic
PPP
Public-Private Partnership
What's next for Archimedic?
With this recent capital deployment, Archimedic is poised to scale its service offerings and deepen its technical infrastructure. The strategic focus will likely center on enhancing its QMS capabilities to meet evolving global regulatory requirements, thereby solidifying its reputation as a premier partner for medical device innovation. As the company continues to navigate the complexities of the healthcare market, this financial backing provides the necessary liquidity to pursue long-term growth initiatives and maintain its competitive edge in high-stakes product development. Future milestones will likely involve expanding its client base and investing in advanced engineering talent to support increasingly sophisticated medical device projects.
See full Archimedic company page
